The Research and Development team at OncoPep is dedicated to advancing the company’s innovative multi-peptide vaccine and multi-tumor antigen T cell therapies. This team conducts cutting-edge research to identify tumor-associated antigens, design and optimize vaccine formulations, and evaluate the efficacy of therapies through rigorous preclinical and clinical studies, all aimed at enhancing cancer treatment options.